Details

Autor(en) / Beteiligte

• Kang, Yingzhu
• Chen, Jiao
• Li, Xiaoying
• Luo, Min
• Chen, Hongli
• Cui, Bomiao
• Wang, Liwei
• Lv, Die
• Feng, Yun
• Zhang, Ping

Titel

Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP

Ist Teil von

• Cancer biomarkers : section A of Disease markers, 2021-01, Vol.31 (4), p.317

Ort / Verlag

Netherlands

Erscheinungsjahr

2021

Link zum Volltext

Beschreibungen/Notizen

• Oral squamous cell carcinoma (OSCC) usually originates from oral potentially malignant disorders (OPMD), such as oral leukoplakia (OLK) and oral lichen planus (OLP). Identifying biomarkers for the early diagnosis and evaluation of malignant transformation in OPMD could improve the survival rate of OSCC patients. The present study aimed to screen for potential salivary biomarkers for evaluating the malignant transformation of OPMD. Salivary proteases from OLK and OSCC patients or healthy donors and proteases in cultural medium from DOK and Cal-27 cells were detected with a human protease array kit. The concentrations of the salivary Kallikrein 5 (KLK5) and urokinase-type plasminogen activator (uPA) proteases were measured by ELISA. Receiver operating characteristics (ROC) to determine the potential value of these proteases in clinical diagnosis were calculated using SPSS software. Immunohistochemistry was used to detect the KLK5 and uPA expression in the oral organizations. The salivary protease spectrum was different among patients with OLK and OSCC and healthy donors. KLK5 and uPA levels in saliva tended to increase as the disease progressed (healthy < OPMD [OLK and OLP] < OSCC). ROC curves showed the optimum diagnostic cutoffs for KLK5 as a biomarker for OLK, OLP, and OSCC were 5.97, 6.03, and 9.45 pg/mL, respectively, while the cutoffs for uPA were 17.19, 17.26, and 20.96 pg/mL. Their combined analysis showed a higher sensitivity for the differential diagnosis of disease. Furthermore, higher levels of KLK5 and uPA were observed in OSCC tissues than in OLK and OLP. Salivary KLK5 and uPA are potential biomarkers for evaluating OLK and OLP malignant transformation and early diagnosis of OSCC.